AbbVie Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $3.61B | $695.0M | $1.82B | $186.0M | $938.0M | $1.29B | $-22.0M | $1.56B |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $194.0M | $188.0M | $203.0M | $192.0M | $186.0M | $181.0M | $206.0M | $191.0M |
| Amortization | $1.70B | $1.75B | $1.72B | $1.90B | $1.90B | $1.86B | $1.93B | $1.90B |
| Stock-Based Compensation | $166.0M | $444.0M | $157.0M | $209.0M | $179.0M | $410.0M | $164.0M | $181.0M |
| Net Cash from Operating Activities | $3.44B | $3.83B | $5.22B | $7.02B | $5.15B | $1.64B | $7.05B | $5.45B |
| Investing Activities | ||||||||
| Capital Expenditures | $322.0M | $265.0M | $329.0M | $381.0M | $269.0M | $235.0M | $291.0M | $249.0M |
| Business Acquisitions | $0 | $0 | $0 | $0 | $0 | $204.0M | $0 | $8.29B |
| Net Cash from Investing Activities | $-1.20B | $-574.0M | $-1.46B | $-3.26B | $-1.18B | $-735.0M | $-1.87B | $-8.26B |
| Financing Activities | ||||||||
| Dividends Paid | $3.07B | $3.09B | $2.91B | $2.91B | $2.91B | $2.93B | $2.75B | $2.75B |
| Stock Repurchases | $9.0M | $1.49B | $3.0M | $4.0M | $12.0M | $961.0M | $358.0M | $17.0M |
| Net Cash from Financing Activities | $-5.05B | $919.0M | $-4.17B | $-4.59B | $-2.71B | $-1.26B | $-6.86B | $-3.07B |
| Net Change in Cash | $-2.82B | $4.16B | $-400.0M | $-838.0M | $1.29B | $-349.0M | $-1.73B | $-5.87B |
| Free Cash Flow | $3.11B | $3.56B | $4.89B | $6.64B | $4.88B | $1.40B | $6.76B | $5.20B |